Fiona Gaughran and Daniel Stahl are are joint first author.
Robin Murray and Shubulade Smith are joint last authors.
People with psychosis have a reduced life expectancy of 10–20 years, largely due to cardiovascular disease. This trial aimed to determine the effectiveness of a modular health promotion intervention (IMPaCT Therapy) in improving health and reducing cardiovascular risk in psychosis.
A multicentre, two arm, parallel cluster RCT was conducted across five UK mental health NHS trusts. Community care coordinators (CC) were randomly assigned to training and supervision in delivering IMPaCT Therapy or treatment as usual (TAU) to current patients with psychosis (cluster). The primary outcome was the physical and mental health subscales of the Short form-36 (SF-36) questionnaire.
Of 104 care coordinators recruited, 52 (with 213 patients) were randomised to deliver IMPaCT therapy and 52 (with 193 patients) randomised to TAU. Of 406 patients, 318 (78%) and 301 (74%) attended 12- and 15-month follow-up respectively. IMPaCT therapy showed no significant effect on the physical or mental health component SF-36 scores versus TAU at 12 or 15 months. No effect was observed for cardiovascular risk indicators, except for HDL cholesterol, which improved more with IMPACT therapy than TAU (Treatment effect (95% CI); 0.085 (0.007 to 0.16); p = 0.034). The 22% of patients who received >180 min of IMPACT Therapy in addition to usual care achieved a greater reduction in waist circumference than did controls, which was clinically significant.
Training and supervising community care coordinators to use IMPaCT therapy in patients with psychosis is insufficient to significantly improve physical or mental health quality of life. The search for effective, pragmatic interventions deliverable in health care services continues.
Walker ER, McGee RE, Druss BG. Mortality in Mental Disorders and Global Disease Burden Implications: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2015;72(4):334-41. doi: 10.1001/jamapsychiatry.2014.2502.
Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ (Clinical Research Ed). 2013;346:f2539–f.
Speyer H, Nørgaard HCB, Hjorthøj C, Madsen TA, Drivsholm S, Pisinger C, et al. Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity. BMC Psychiatry. 2015;15(1):1–11. CrossRef
Mitchell AJ, Vancampfort D, De Hert M, Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. Gen Hosp Psychiatry. 2015;37(1):14-23. doi: 10.1016/j.genhosppsych.2014.11.006. Epub 2014 Nov 21.
Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, Bush R, Castle D, Cohen M, Harvey C, Galletly C, Stain HJ, Neil AL, McGorry P, Hocking B, Shah S, Saw S. People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry. 2012;46(8):735–52. doi: 10.1177/0004867412449877. Epub 2012 Jun 13. CrossRefPubMed
Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–47. CrossRefPubMedPubMedCentral
Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J, on behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS study. Schizophr Res. 2007;90(1–3):162–73. Epub 2006 Nov 21 CrossRefPubMed
Speyer H, Christian Brix Norgaard H, Birk M, Karlsen M, Storch Jakobsen A, Pedersen K, et al. The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity. World Psychiatry. 2016;15(2):155–65. CrossRefPubMedPubMedCentral
Greenwood K, Smith S, Atakan Z. Impact - the reference guide: improving physical health and treating substance use in mental illness. 2011.
Medical Research Council. Framework for the development and evaluation of RCTs for complex interventions to improve health. London: MRC; 2000. p. 18.
Medical Research Council. Developing and evaluating complex interventions: new guidance. London: MRC; 2006. www.mrc.ac.uk/complexinterventionsguidance
Drake RE, O’Neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abus Treat. 2008;34:123–38. CrossRef
Barrowclough C, Haddock G, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Lewis S, Moring J, Tarrier N, Wykes T. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addict Behav. 2009;34(10):859–66. doi: 10.1016/j.addbeh.2009.03.007. CrossRefPubMed
Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ (Clinical Research Ed). 2012;345:e5661–e.
Gaughran F, Stahl D, Ismail K, Atakan Z, Lally J, Gardner-Sood P, et al. Improving physical health and reducing substance use in psychosis -- randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial. BMC Psychiatry. 2013;13(1):305–26. CrossRef
Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J. 1990;69(11):763–5. PubMed
Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen JP, editors. Measuring alcohol consumption: psychosocial and biochemical methods. Totowa: Humana Press; 1992. p. 41–72. CrossRef
American Psychiatric Association. Multiaxial assessment. In Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revised) (DSM–IV–TR). Washington, DC: American Psychiatric Association; 2002.
Garety PA, Craig TKJ, Iredale C, Basit N, Fornells-Ambrojo M, Halkoree R, Jolley S, Landau S, McCrone P, Tunnard C, Zala D, Waller H. Training the frontline workforce to deliver evidence-based therapy to people with psychosis: challenges in the GOALS study. Psychiatr Serv. In press.
Slade M, Bird V, Clarke E, et al. Supporting recovery in patients with psychosis through care by community-based adult mental health teams (REFOCUS): a multisite, cluster, randomised, controlled trial. Lancet. 2015;2:503–14. PubMed
Curtis J, Watkins A, Rosenbaum S, TEasdale S, Kalucy M, Samaras K, Ward PB. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Interv Psychiatry. 2015; doi: 10.1111/eip.12230.
Lee DC, Sui X, Artero EG, Lee IM, Church TS, McAuley PA, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the aerobics center longitudinal study. Circulation. 2011;124(23):2483–90. CrossRefPubMedPubMedCentral
- Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)
Anthony S. David
on behalf of the IMPaCT Team
- BioMed Central